InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,577.83
(
0.09%
)
US TECH 100
19,890.00
(
-0.02%
)
Dow Jones
39,312.30
(
-0.08%
)
Brent Oil
84.45
(
-1.14%
)
Bitcoin
57,763.03
(
1.86%
)
Post# of 252530
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

poorgradstudent

Send PM Follow Ignore
Followers 73
Posts 3426
Boards Moderated 1
Alias Born 04/28/2004

poorgradstudent

Re: spartex post# 25620

Tuesday, 03/14/2006 1:56:40 PM

Tuesday, March 14, 2006 1:56:40 PM

Post# of 252530
Bottom line with P-11:

Even the company can't articulate what is expected from p-11 with respect to efficacy.

That should tell investors all they need to know regarding the potential impact of this trial on ADPC treatment strategies.

At the risk of alerting the hypothesis police, p-11 is just that... hypothesis generating.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up